Live News Categoriesequity

Akeso, Inc. (AKESF) News

Follow Akeso, Inc. (AKESF) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol AKESF Asset equity Sector Markets 90 days 1 Last 11.45 Updated Sep 13, 2026, 05:23 PM UTC Open live news feed Open AKESF chart & news

L Summit’s ivonescimab cuts death risk by 27% versus Keytruda in lung cancer trial Summit Therapeutics NASDAQ:SMMT on Sunday said ivonescimab significantly extended survival compared with Merck’s NYSE:MRK Keytruda in a late-stage lung cancer trial conducted by its partner Akeso OTC:AKESF in China.Ivone GEOPOLITICS | Sep 13, 2026, 05:23 PM UTC